These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 9652969)

  • 21. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey.
    Roy BN; Reid RL; Van Vugt DA
    Endocrinology; 1999 May; 140(5):2191-8. PubMed ID: 10218971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenalectomy dramatically modifies the dynamics of neuropeptide and c-fos gene responses to stress in the hypothalamic paraventricular nucleus.
    Tanimura SM; Watts AG
    J Neuroendocrinol; 2000 Aug; 12(8):715-22. PubMed ID: 10929082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats.
    Grinevich V; Ma XM; Herman JP; Jezova D; Akmayev I; Aguilera G
    J Neuroendocrinol; 2001 Aug; 13(8):711-23. PubMed ID: 11489088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
    Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
    Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restraint-induced corticosterone secretion and hypothalamic CRH mRNA expression are augmented during acute withdrawal from chronic cocaine administration.
    Mantsch JR; Taves S; Khan T; Katz ES; Sajan T; Tang LC; Cullinan WE; Ziegler DR
    Neurosci Lett; 2007 Mar; 415(3):269-73. PubMed ID: 17293045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
    Al-Barazanji KA; Wilson S; Baker J; Jessop DS; Harbuz MS
    J Neuroendocrinol; 2001 May; 13(5):421-4. PubMed ID: 11328451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration.
    Aguilera G; Kiss A; Luo X
    J Neuroendocrinol; 1995 Oct; 7(10):775-83. PubMed ID: 8563720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ontogeny of hypothalamic glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in mice.
    Laryea G; Arnett M; Muglia LJ
    Stress; 2015; 18(4):400-7. PubMed ID: 26068518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olfactory bulbectomy increases vasopressin, but not corticotropin-releasing hormone, content in the external layer of the median eminence of male rats.
    Marcilhac A; Anglade G; Hery F; Siaud P
    Neurosci Lett; 1999 Mar; 262(2):89-92. PubMed ID: 10203238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA.
    Ma XM; Levy A; Lightman SL
    Endocrinology; 1997 Oct; 138(10):4351-7. PubMed ID: 9322950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of pituitary corticotropin releasing hormone (CRH) receptor mRNA and CRH binding during adrenalectomy: role of glucocorticoids and hypothalamic factors.
    Rabadan-Diehl C; Makara G; Kiss A; Zelena D; Aguilera G
    J Neuroendocrinol; 1997 Sep; 9(9):689-97. PubMed ID: 9355036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids.
    Luo X; Kiss A; Rabadan-Diehl C; Aguilera G
    Endocrinology; 1995 Sep; 136(9):3877-83. PubMed ID: 7649095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brainstem hemisection decreases corticotropin-releasing hormone mRNA in the paraventricular nucleus but not in the central amygdaloid nucleus.
    Pacak K; Palkovits M; Makino S; Kopin IJ; Goldstein DS
    J Neuroendocrinol; 1996 Jul; 8(7):543-51. PubMed ID: 8843023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intact catecholamine inputs to the forebrain are required for appropriate regulation of corticotrophin-releasing hormone and vasopressin gene expression by corticosterone in the rat paraventricular nucleus.
    Kaminski KL; Watts AG
    J Neuroendocrinol; 2012 Dec; 24(12):1517-26. PubMed ID: 22831701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs.
    Choi DC; Furay AR; Evanson NK; Ostrander MM; Ulrich-Lai YM; Herman JP
    J Neurosci; 2007 Feb; 27(8):2025-34. PubMed ID: 17314298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of hypothalamic-pituitary-adrenal axis stress responses in late pregnancy: changes in feedforward and feedback mechanisms.
    Johnstone HA; Wigger A; Douglas AJ; Neumann ID; Landgraf R; Seckl JR; Russell JA
    J Neuroendocrinol; 2000 Aug; 12(8):811-22. PubMed ID: 10929094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgens Drive Sex Biases in Hypothalamic Corticotropin-Releasing Hormone Gene Expression After Adrenalectomy of Mice.
    Heck AL; Handa RJ
    Endocrinology; 2019 Jul; 160(7):1757-1770. PubMed ID: 31074799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses.
    Chan O; Chan S; Inouye K; Shum K; Matthews SG; Vranic M
    Diabetes; 2002 Jun; 51(6):1681-9. PubMed ID: 12031953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic-pituitary-adrenocortical responses to single vs. repeated endotoxin lipopolysaccharide administration in the rat.
    Takemura T; Makino S; Takao T; Asaba K; Suemaru S; Hashimoto K
    Brain Res; 1997 Sep; 767(2):181-91. PubMed ID: 9367246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.